| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +23% |
| 3Y CAGR | +6% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +33% |
| 3Y CAGR | +7.0% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ₹8,310.50 +68.50 (0.83%) | 20,589.75 | 109.8 | 23.59 | ||
PfizerPFIZER | ₹4,568.60 +129.20 (2.91%) | 20,301.47 | 28.1 | 4.83 | ||
₹1,431.10 -17.60 (1.21%) | 20,055.78 | 30.97 | 5.14 | |||
Natco PharmaNATCOPHARM | ₹931.40 -3.10 (0.33%) | 16,725.28 | 11.79 | 1.81 |